PFIZER INC - 17 Mar 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Reporting relationship: 10%+ Owner
Issuer ticker: PYXS
Reported as of: 17 Mar 2023
Net transaction value: +$4,999,999
SEC form: 4
Accepted by SEC: 21 Mar 2023, 18:07:27 UTC
Prior SEC filing: 29 Dec 2022
Next SEC filing: 30 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Susan Grant, Assistant Secretary

Key filing fact

PFIZER INC filed Form 4 for Pyxis Oncology, Inc. (PYXS) on 21 Mar 2023.

Key facts

This page summarizes PFIZER INC's Form 4 filing for Pyxis Oncology, Inc. (PYXS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Mar 2023, 18:07.

Change

Previous filing in this sequence was filed on 29 Dec 2022.
Current net transaction value: +$4,999,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

This filing has been restated. Open the amended filing.

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PYXS transaction

Common Stock, $0.001 par value per share

Purchase

Transaction value: $4,999,999
Shares: +1,811,594
Change %: +44%
Price: $2.76
Shares after: 5,952,263
Date: 17 Mar 2023
Ownership: Direct

PYXS holding

Common Stock, $0.001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,080,507
Date: 17 Mar 2023
Ownership: By Pfizer Ventures (US) LLC
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .